Palliative care for people who use substances during communicable disease epidemics and pandemics: a scoping review protocol

Abstract

IntroductionCommunicable disease epidemics and pandemics magnify the health inequities experienced by marginalised populations. People who use substances suffer from high rates of morbidity and mortality and should be a priority to receive palliative care, yet they encounter many barriers to palliative care access. Given the pre-existing inequities to palliative care access for people with life-limiting illnesses who use substances, it is important to understand the impact of communicable disease epidemics and pandemics such as COVID-19 on this population.Methods and analysisWe will conduct a scoping review and report according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews reporting guidelines. We conducted a comprehensive literature search in seven bibliographical databases from the inception of each database to August 2020. We also performed a grey literature search to identify the publications not indexed in the bibliographical databases. All the searches will be rerun in April 2021 to retrieve recently published information because the COVID-19 pandemic is ongoing at the time of this writing. We will extract the quantitative data using a standardised data extraction form and summarise it using descriptive statistics. Additionally, we will conduct thematic qualitative analyses and present our findings as narrative summaries.Ethics and disseminationEthics approval is not required for a scoping review. We will disseminate our findings to healthcare providers and policymakers through professional networks, digital communications through social media platforms, conference presentations and publication in a scientific journal.

Palliative care interventions for people who use substances during communicable disease outbreaks: a scoping review

“…We published our scoping review’s protocol as an open-access journal article in October 2021. 8 We based our methodology on the Joanna Briggs Institute’s Manual for Evidence Synthesis, 9 which builds on the contributions from Arksey and O’Malley 10 and Levac et al , 11 and the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) reporting guidelines. 12 …”

“…We published our scoping review's protocol as an openaccess journal article in October 2021. 8 We based our methodology on the Joanna Briggs Institute's Manual for Evidence Synthesis, 9 which builds on the contributions from Arksey and O'Malley 10 and Levac et al, 11 and the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRIS-MA-ScR) reporting guidelines. 12 Eligibility criteria Table 1 summarises the PECOS (Population, Exposure, Comparison or Control, Outcomes and Study Characteristics) framework that we used to structure the evidence eligibility criteria.…”

Palliative care for people who use drugs during communicable disease epidemics and pandemics: A scoping review on access, policies, and programs and guidelines

“…This paper is part of a larger knowledge synthesis project focused on palliative care for people who use drugs during epidemics and pandemics. 26 , 27 We conducted a preliminary search of the PubMed and Web of Science databases in May 2020 and we did not identify any reviews addressing palliative care needs for people who use substances during communicable disease outbreaks (e.g. Ebola, H1N1).…”